St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0316268 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yanxia Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Lysosomes, Docetaxel, Drug Resistance, Neoplasm, Glucosides. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, Jinan Clinical Medical Science and Technology Innovation Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Drug resistance of cancers remains a major obstacle due to limited therapeutics. Lysosome targeting is an effective method for overcoming drug resistance in cancer cells. St-N ( ent -13-hydroxy-15-kaurene-19-acid N -methylpiperazine ethyl ester) is a novel alkaline stevioside derivative with an amine group. In this study, we found that docetaxel (Doc)-resistant prostate cancer (PCa) cells were sensitive to St-N. Mechanistically, the alkaline characteristic of St-N led to targeting lysosomes, as evidenced by lysosomal swelling and rupture through transmission electron microscopy and Lyso-tracker Red staining. St-N destabilized lysosomal membrane by impairing lysosomal membrane proteins and acid sphingomyelinase. As a result, St-N caused cathepsins to release from the lysosomes into the cytosol, eventually triggering apoptotic and necrotic cell death. Meanwhile, the cytoprotective role of lysosomal activation under docetaxel treatment was interrupted by St-N, leading to significant synergistic cytotoxicity of docetaxel and St-N. In docetaxel-resistant PCa homograft mice, St-N significantly inhibited the growth of RM-1/Doc homografts and enhanced the anticancer effects of docetaxel, but did not show significant toxicity. Taken together, these findings demonstrated that St-N reversed docetaxel resistance in vitro and in vivo by destabilizing lysosomal membranes to promote cell death, thus providing a strong rationale for applying St-N in docetaxel-resistant PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Engineering Laboratory of Urinary Organ and Functional Reconstruction of Shandong Province, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Department of Pharmacy, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Pharmacy, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Yongqing Liu
Förderung
- Natural Science Foundation of Shandong Province
- Jinan Clinical Medical Science and Technology Innovation Plan
- National Natural Science Foundation of China
- Academic Promotion Program of Shandong Provincial Hospital Affiliated to Shandong First Medical University
Zitieren
APA
Guo, Y., Wang, S., Liu, Q., Dong, Y., & Liu, Y. (2024). St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo. PLOS ONE. https://doi.org/10.1371/journal.pone.0316268
Vancouver
Guo Y, Wang S, Liu Q, Dong Y, Liu Y. St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo. PLOS ONE. 2024. doi:10.1371/journal.pone.0316268
BibTeX
@article{Guo2024,
author = {Guo, Yanxia and Wang, Shikang and Liu, Qun and Dong, Yan and Liu, Yongqing},
title = {St-N, a novel alkaline derivative of stevioside, reverses docetaxel resistance by targeting lysosomes in vitro and in vivo},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0316268}
}
EUVIMED